503536-73-0Relevant articles and documents
Discovery of thienothiazolocarboxamide analogues as novel anti-tubercular agent
Carla, Virginia,Choi, Inhee,Choi, Junghwan,Delorme, Vincent,Heo, Jinyeong,Jea Seo, Jeong,Jin, Guanghai,Kang, Juhee,Kang, Sunhee,Kim, Jaeseung,Lee, Aram,Lee, Honggun,Lee, Sumi,Mi Kim, Young,Park, Kaapjoo,Park, Sinyoung,Seo, Mooyoung,Shum, David,Woo, Minjeong
, (2020/10/21)
In order to identify anti-tubercular agents with a novel scaffold, commercial libraries of small organic compounds were screened against a fluorescent strain of Mycobacterium tuberculosis H37Rv, using a dual phenotypic assay. Compounds were assessed again
Synthesis and evaluation of the anticoccidial activity of trifluoropyrido[1,2-a]pyrimidin-2-one derivatives
Silpa, Laurence,Niepceron, Alisson,Laurent, Fabrice,Brossier, Fabien,Pénichon, Mélanie,Enguehard-Gueiffier, Cécile,Abarbri, Mohamed,Silvestre, Anne,Petrignet, Julien
, p. 114 - 120 (2015/12/18)
Screening of our chemical library to discover new molecules exhibiting in vitro activity against the invasion of host cells by Eimeria tenella revealed a lead compound with an IC50 of 15 μM. Structure-activity relationship studies were conducted with 34 newly synthesized compounds to identify more active molecules and enhance in vitro activity against the parasite. Four compounds were more effective in inhibiting MDBK cell invasion in vitro than the lead compound.
Peptide deformylase inhibitors
-
Page/Page column, (2014/12/09)
The present invention relates to a compound of Formula (I): or a pharmaceutically acceptable salt thereof, corresponding pharmaceutical compositions, compound preparation and treatment methods directed to bacterial infections and inhibition of bacterial peptide deformylase (PDF) activity.